Production

MiraxBioPharma has been collaborating with Russian and international pharmaceutical companies for many years under contract manufacturing agreements.

Our strengths

from 10 days

brand launch from scratch

from 500 units

per production batch

GMP, GCP, GLP, ISО

compliance with Russian and international standards

«Chestny znak»

release with national product labeling system

Delivery

operations across Russia and the CIS

Marketplaces

packaging adapted for online sales

Our production facilities allow us to manufacture daily:

  • 770 000 capsules
  • 450 000 tablets
  • 15 000 sachets

Dosage forms

Sachets, capsules, tablets, liquid forms

Packaging options

Blisters, jars, bottles

Would you like to see the production process? We invite you to visit our factory

Our technologies

You can see our production facilities in action at the MiraxBioPharma plant. We invite you to visit!

Dry encapsulation

Sachet packaging

Liquid filling

Tablet coating

Liquid encapsulation into hard capsules

Tableting

Contact us

Select a service*

Filling out these documents will significantly speed up the processing of your request and the cost calculation

Download the documents, fill in the required information, and upload them through the form. If you have already submitted the form, you can also send the documents and your request to our e-mail cp@mbpharma.ru

Contact us

Select a service*

Pharmacovigilance

MiraxBioPharma is committed to ensuring the quality and safety of its products and pays special attention to collecting and analyzing information about adverse reactions and complaints associated with the use of our products.

If you become aware of any adverse reactions to the medicinal product Cezarox® Epi or of a lack of therapeutic effect, please report it via email at: adversareaction@drugsafety.ru or by phone: +7 (800) 777-86-04.

If you become aware of any adverse reactions to other MiraxBioPharma medicinal products or of a lack of therapeutic effect, please report it via email at: GVP@mbpharma.ru, by phone: +7 (495) 183-38-41 or by filling out the electronic form below

Adverse reaction reporting form
Specify gender*
Suspected medicinal product information
Reporter information

Preferred method of contact*
We use cookies

By using this website, you consent to the collection and processing of your personal data, including through third-party services, and the use of cookies and web analytics tools, under the terms outlined in the Personal Data Processing Policy.